Download PDF
kleintier konkret 2024; 27(03): 41-53
DOI: 10.1055/a-2158-2224
Innere Medizin

Diagnostisches und therapeutisches Vorgehen bei der Proteinverlust-Enteropathie (PLE) des Hundes – altbekannt und doch vieles neu

Linus Zündorff
,
Sebastian Vockert
,
Romy M. Heilmann
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Die Proteinverlust-Enteropathie des Hundes kann durch verschiedene Ursachen bedingt sein, sodass eine umfassende Diagnostik zur Wahl der geeigneten Therapie essenziell ist. Dieser Artikel gibt eine Übersicht über das diagnostische Vorgehen sowie die aktuellen therapeutischen Aspekte der PLE beim Hund.

Publication History

Article published online:
20 June 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Jablonski SA. Pathophysiology, diagnosis, and management of canine intestinal lymphangiectasia: a comparative review. Animals 2022; 12: 2791
    CrossrefPubMedGoogle Scholar
  • 2 Dossin O, Lavoué R. Protein-losing enteropathies in dogs. Vet Clin North Am Small Anim Pract 2011; 41: 399-418
    CrossrefPubMedGoogle Scholar
  • 3 Jergens AE, Heilmann RM. Canine chronic enteropathy–current state-of-the-art and emerging concepts. Front Vet Sci 2022; 9: 923013
    CrossrefPubMedGoogle Scholar
  • 4 Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. J Vet Intern Med 2019; 33: 383-402
    CrossrefPubMedGoogle Scholar
  • 5 Xenoulis PG, Steiner JM. Lipid metabolism and hyperlipidemia in dogs. Vet J 2010; 183: 12-21
    CrossrefPubMedGoogle Scholar
  • 6 Jacinto AML, Ridyard AE, Aroch I. et al. Thromboembolism in dogs with protein-losing enteropathy with non-neoplastic chronic small intestinal disease. J Am Anim Hosp Assoc 2017; 53: 185-192
    CrossrefPubMedGoogle Scholar
  • 7 Jergens AE, Schreiner CA, Frank DE. et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003; 17: 291-297
    CrossrefPubMedGoogle Scholar
  • 8 Allenspach K, Wieland B, Gröne A. et al. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007; 21: 700-708
    CrossrefPubMedGoogle Scholar
  • 9 Wennogle SA, Priestnall SL, Webb CB. Histopathologic characteristics of intestinal biopsy samples from dogs with chronic inflammatory enteropathy with and without hypoalbuminemia. J Vet Intern Med 2017; 31: 371-376
    CrossrefPubMedGoogle Scholar
  • 10 Heilmann RM, Parnell NK, Grützner N. et al. Serum and fecal canine alpha1-proteinase inhibitor concentrations reflect the severity of intestinal crypt abscesses and/or lacteal dilation in dogs. Vet J 2016; 207: 131-139
    CrossrefPubMedGoogle Scholar
  • 11 Heilmann RM, Becher A, Dengler F. Electrolyte imbalances in dogs with chronic inflammatory enteropathies. Top Companion Anim Med 2022; 46: 100597
    CrossrefPubMedGoogle Scholar
  • 12 Kather S, Grützner N, Kook PH. et al. Review of cobalamin status and disorders of cobalamin metabolism in dogs. J Vet Intern Med 2020; 34: 13-28
    CrossrefPubMedGoogle Scholar
  • 13 Heilmann RM, Steiner JS. Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs. J Vet Intern Med 2018; 32: 1495-1508
    CrossrefPubMedGoogle Scholar
  • 14 Titmarsh H, Gow AG, Kilpatrick S. et al. Association of vitamin D status and clinical outcome in dogs with a chronic enteropathy. J Vet Intern Med 2015; 29: 1473-1478
    CrossrefPubMedGoogle Scholar
  • 15 Allenspach K, Rizzo J, Jergens AE. et al. Hypovitaminosis D is associated with negative outcome in dogs with protein losing enteropathy: a retrospective study of 43 cases. BMC Vet Res 2017; 13: 96
    CrossrefPubMedGoogle Scholar
  • 16 Heilmann RM, Paddock CG, Ruhnke I. et al. Development and analytical validation of a radioimmunoassay for the measurement of alpha1-proteinase inhibitor concentrations in feces from healthy puppies and adult dogs. J Vet Diagn Invest 2011; 23: 476-485
    CrossrefPubMedGoogle Scholar
  • 17 Gaschen L, Kircher P, Stüssi A. et al. Comparison of ultrasonographic findings with clinical activity index (CIBDAI) and diagnosis in dogs with chronic enteropathies. Vet Radiol Ultrasound 2008; 49: 56-64
    CrossrefPubMedGoogle Scholar
  • 18 Euler CC, von Bomhard W, Siebenaller C. et al. Fokale intestinale lipogranulomatöse Lymphangitis bei einem Havaneser-Rüden. Kleintierpraxis 2023; 68: 342-349
    Google Scholar
  • 19 Lee HW, Jung JW, Park S. et al. Computed tomographic features of focal lipogranulomatous lymphangitis for differentiating from malignant intestinal lesions in a dog. J Vet Sci 2023; 24: e25
    CrossrefPubMedGoogle Scholar
  • 20 Larson RN, Ginn JA, Bell CM. et al. Duodenal endoscopic findings and histopathologic confirmation of intestinal lymphangiectasia in dogs. J Vet Intern Med 2012; 26: 1087-1092
    CrossrefPubMedGoogle Scholar
  • 21 Okanishi H, Yoshioka R, Kagawa Y. et al. The clinical efficacy of dietary fat restriction in treatment of dogs with intestinal lymphangiectasia. J Vet Intern Med 2014; 28: 809-817
    CrossrefPubMedGoogle Scholar
  • 22 Nagata N, Ohta H, Yokoyama N. et al. Clinical characteristics of dogs with food-responsive protein-losing enteropathy. J Vet Intern Med 2020; 34: 659-668
    CrossrefPubMedGoogle Scholar
  • 23 Myers M, Martinez SA, Shiroma JT. et al. Prospective evaluation of low-fat diet monotherapy in dogs with presumptive protein-losing enteropathy. J Am Anim Hosp Assoc 2023; 59: 74-84
    CrossrefPubMedGoogle Scholar
  • 24 Wootton FE, Hoey CSFK, Woods G. et al. An undernutrition screening score for dogs with protein-losing enteropathy: A prospective multicenter study. J Vet Intern Med 2023; 37: 1821-1829
    CrossrefPubMedGoogle Scholar